Association between 5-alpha reductase inhibition and risk of hip fracture

scientific article published in October 2008

Association between 5-alpha reductase inhibition and risk of hip fracture is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/JAMA.300.14.1660
P698PubMed publication ID18840839
P5875ResearchGate publication ID23305234

P50authorSteven J JacobsenQ37384936
Reina HaqueQ88303669
P2093author name stringT Craig Cheetham
Ronald K Loo
Jiaxiao M Shi
P433issue14
P407language of work or nameEnglishQ1860
P304page(s)1660-1664
P577publication date2008-10-01
P1433published inThe Journal of the American Medical AssociationQ1470970
P1476titleAssociation between 5-alpha reductase inhibition and risk of hip fracture
P478volume300

Reverse relations

cites work (P2860)
Q43675196A population-based nested case-control study: the use of 5-alpha-reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
Q55380284A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride.
Q34395346Androgens and estrogens in skeletal sexual dimorphism.
Q51452748DHEA administration activates local bioactive androgen metabolism in cancellous site of tibia of ovariectomized rats.
Q34556225Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
Q48970211Dutasteride improves bone mineral density in male patients with lower urinary tract symptoms and prostatic enlargement: a preliminary study.
Q43842409Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: a prospective study
Q34543980Estrogens and Androgens in Skeletal Physiology and Pathophysiology
Q39168087Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
Q33610301Male osteoporosis and androgenic therapy: from testosterone to SARMs.
Q39042961Risk for Hip Fracture due to Alpha Blocker Treatment in Korean Women: National Health Insurance Database Study
Q35808841Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study
Q57153138Risk of fractures associated with treatment for benign prostate hyperplasia in men
Q36243696Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study
Q34437537Sex steroid actions in male bone
Q28301391Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
Q36206485The risk of fall and fracture with the initiation of a prostate-selective α antagonist: a population based cohort study

Search more.